Armed to the hilt: Study solves mystery behind bacteria’s extensive weaponry
1 December 2023
A new study led by the University of Oxford has shed light on why certain species of bacteria carry astonishing arsenals of weapons. The new findings, published in the journal Nature Ecology & Evolution, could help us to engineer microbes that can destroy deadly pathogens, reducing our reliance on antibiotics.
Kennedy Trust gift to help drive forward research into inflammatory and musculoskeletal diseases at Oxford
30 November 2023
Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.
Clinicians, practices, and patients all have a part to play in dealing with risks of remote consulting, new Oxford-led study reveals
29 November 2023
While most remote GP consultations are safe, the 'Remote by Default' study finds that GP consultations conducted remotely carry more risk for patients with some urgent conditions.
Nuffield Department of Primary Care Health Sciences set to deliver clinical trials expertise to China National Biotec Group in new collaboration
28 November 2023
The training initiative builds the foundations to explore further collaborations encompassing joint research efforts, leadership programmes, and a shared commitment to advancing clinical trials.
Oxford-Harrington Rare Disease Centre named in first global initiative for children with rare diseases
27 November 2023
In the autumn statement on Wednesday 22 November, the government announced its support for the Rare Therapies Launch Pad, a new programme that will develop regulatory pathways for children with rare conditions to access individualised therapies.
Unlocking the secrets of the gut microbiome
24 November 2023
Undaunted by its complexity, Professor Emma Slack is pioneering new methods of engineering the body’s largest microbiome to improve health and protect against disease.
Oxford-led study shows how AI can detect antibiotic resistance in as little as 30 minutes
21 November 2023
To mark World Antimicrobial Awareness Week, researchers supported by the Oxford Martin Programme on Antimicrobial Resistance Testing at the University of Oxford have reported advances towards a novel and rapid antimicrobial susceptibility test that can return results within as little as 30 minutes - significantly faster than current gold-standard approaches.
Antimicrobial resistance is a silent killer that leads to 5 million deaths a year. Solutions must include the poor
17 November 2023
Microbes such as bacteria, viruses, parasites and fungi form part of our everyday lives – they live in us, on us and around us. We need them for healthy digestion, immune function, and the synthesis of essential nutrients, and we depend on them for farming and industrial processes. But microbes also cause disease in people, animals and plants.
Flies neglect food and endure shocks to seek a dopamine reward
17 November 2023
New research published in nature, led by Department of Physiology, Anatomy and Genetics (DPAG) scientists Dr Kristijan Jovanoski and Professor Scott Waddell at the Centre for Neural Circuits and Behaviour, reveals dopamine systems can cause flies to seek reward despite negative consequences
Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa
16 November 2023
The Pandemic Sciences Institute (PSI) has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
£4.3m boost for Oxford-Glasgow spinout tackling antimicrobial resistance
15 November 2023
Glox Therapeutics, a company pioneering the development of precision antibiotics to combat antimicrobial resistance, has raised £4.3M in early-stage funding to develop effective targeted therapeutics against antibiotic-resistant gram-negative bacteria.
AI tool could help thousands avoid fatal heart attacks
14 November 2023
An Artificial Intelligence (AI) tool that can predict 10-year risk of deadly heart attacks, could transform treatment for patients who undergo CT scans to investigate chest pain, according to British Heart Foundation-funded research presented today at the American Heart Association’s Scientific Sessions in Philadelphia.
Heart attack risk decreased in new mothers by self-monitoring blood pressure at home
13 November 2023
Self-monitoring blood pressure after giving birth could help to cut new mothers’ risk of future heart disease and strokes, according to new research by Oxford researchers.
Single cell spatial analysis provides new insight into immune-pathology in Covid-19 lungs
9 November 2023
Coronavirus COVID-19 General Research
A Nature Communications study led by Professor Ling-Pei Ho’s group in the MRC Translational Immune Discovery Unit (TIDU) provides new insights into how immune cells interact in the lungs of patients with severe COVID-19.
New discovery furthers our understanding of how critical immune cells are controlled during an infection
9 November 2023
A recent publication from Research from the Gerard Lab in Kennedy Institute of Rheumatology looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection.
Partnership with Danaher paves way for precision medicine test for sepsis
8 November 2023
The University of Oxford today announced a partnership with Danaher Corporation to develop a new test to enable precision medicine care for sepsis, a pathological immune response to infection that accounts for one in five deaths globally each year.
MSD Teaching Excellence Awards 2023
7 November 2023
Awards and Appointments General
The 2023 MSD Teaching Excellence Awards have been celebrated in a ceremony at Oxford Town Hall, on Tuesday 31st October. The ceremony was hosted by the Head of Division, Professor Gavin Screaton, the Associate Head of Division (Education), Professor Helen Christian, and the Head of Education Policy and Planning, Jane Dale.
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa
6 November 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
6 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, while also looking to improve manufacturing speed and scale-up of ChAdOx technology. Learnings could be leveraged to inform vaccine design for related viruses from the Arenavirus family, giving the world a head start in rapidly responding to future outbreaks in as little as 100 days. First project to be initiated under CEPI and University of Oxford’s strategic partnership to accelerate global pandemic preparedness efforts.
Celebrating 5 Years of the BioEscalator
1 November 2023
The BioEscalator recently marked its 5th anniversary with a celebration that showcased the impressive journeys of some of its current and graduated biotech companies.